Suppliers / Hemmo Pharmaceuticals

Hemmo Pharmaceuticals

India 57 employees Updated 9 July 2026

Hemmo Pharmaceuticals is an API manufacturer based in India. It holds one active US drug master file across a filed portfolio of 2 molecules. Its filings concentrate with CDSCO (India) and MINSA (CR). Customs aggregates show $13.1M of exports covering 321 molecules to 40 destinations in 2022.

1
active US DMFs
0
valid CEPs
0
registered plants
2
filings across 2 regulators

What they file, and where

Molecule Regulators Docs
Oxytocin US FDA 1
Tetracosactide SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Oxytocin API

Filings and GMP by regulator

Regulator Filings GMP certificates
CDSCO (India) 1 None
MINSA (CR) 1 None

Scale

Year Revenue Exports Destinations
2022 Not reported $13.1M 40

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Hemmo Pharmaceuticals

Does Hemmo Pharmaceuticals hold a US DMF or a CEP?
Hemmo Pharmaceuticals holds 1 active US drug master file. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Hemmo Pharmaceuticals make?
2 molecules are on record against Hemmo Pharmaceuticals, including Oxytocin and Tetracosactide. Each links through to that molecule's full manufacturer list.
Where does Hemmo Pharmaceuticals file?
Filings are on record with CDSCO (India) and MINSA (CR), 2 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Checking Hemmo Pharmaceuticals?

Ask Fred what the record holds on Hemmo Pharmaceuticals, including filings and inspection history.

Chat with Fred, your AI analyst
Opens WhatsApp. Free to start.

Comparable suppliers

Piramal Pharma shares 1 molecule Aspen Oss shares 1 molecule Hybio Pharmaceutical shares 1 molecule Shenzhen Jymed Technology shares 1 molecule Joint Stock Company “Grindeks” shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
Customs aggregates
Export values, molecule and destination counts